Clinical trial
A Randomized, Controlled Trial of Fluorouracil Implants Regional Chemotherapy During the Surgical Treatment for Early Stage Hepatocellular Carcinoma
NCT01055743 is registered in ClinicalTrials.gov with Simcere Pharmaceutical Co., Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Controlled Trial of Fluorouracil Implants Regional Chemotherapy During the Surgical Treatment for Early Stage Hepatocellular Carcinoma
- Lead sponsor
- Simcere Pharmaceutical Co., Ltd
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- August 31, 2009
- Completion date
- August 31, 2014
- Enrollment
- 250 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
early stage hepatocellular carcinoma